FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Olmesartan Medoxomil and Hydrochlorothiazide Tablets
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Teva Pharmaceuticals (New 06/21/2018)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
Olmesartan Medoxomil and Hydrochlorothiazide 20mg/12.5mg, 30 count, (NDC 0093-7615-56) 06/21/2018 This was a business-related decision to discontinue manufacturing these products.
Olmesartan Medoxomil and Hydrochlorothiazide 20mg/12.5mg, 90 count, (NDC 0093-7615-98) 06/21/2018 This was a business-related decision to discontinue manufacturing these products.
Olmesartan Medoxomil and Hydrochlorothiazide 40mg/12.5mg, 30 count, (NDC 0093-7616-56) 06/21/2018 This was a business-related decision to discontinue manufacturing these products.
Olmesartan Medoxomil and Hydrochlorothiazide 40mg/12.5mg, 90 count, (NDC 0093-7616-98) 06/21/2018 This was a business-related decision to discontinue manufacturing these products.
Olmesartan Medoxomil and Hydrochlorothiazide 40mg/25mg, 30 count, (NDC 0093-7617-56) 06/21/2018 This was a business-related decision to discontinue manufacturing these products.
Olmesartan Medoxomil and Hydrochlorothiazide 40mg/25mg, 90 count, (NDC 0093-7617-98) 06/21/2018 This was a business-related decision to discontinue manufacturing these products.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English